← SynDRA
olsalazine
SynDRA canonical compound SYN0041492 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | IFNG | PTGS1 | PTGS2 | TPMT |
|---|
| Mechanism of action | cyclooxygenase inhibitor |
|---|
| Indication | ulcerative colitis |
|---|
| Disease area | gastroenterology |
|---|
All known targets
- PTGS1
- PTGS2
- ALOX5
- BLVRB
- IFNG
- PPARG
- TPMT
Mechanisms of action (all sources)
- cyclooxygenase inhibitor
- ALOX5 INHIBITOR
- PPARG AGONIST
- PTGS1 INHIBITOR
- PTGS2 INHIBITOR
Drug classes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Gastrointestinal Agents
- Peripheral Nervous System Agents
- Sensory System Agents
- Aminosalicylate
ATC classes
- INTESTINAL ANTIINFLAMMATORY AGENTS
Cross-references
Synonyms
- olsalazine sodium
- CJ 91B
- dipentum
- azodisalicylate
- Olsalazina
- Olsalazinum
- Dipentum
- 5,5'-Azobis(salicylic acid)
- 3,3'-Azobis(6-hydroxybenzoic acid)
- C. i. mordant yellow 5
- Azodisal
- 5,5'-azodisalicylic acid
- ULS5I8J03O
- 5,5'-(diazene-1,2-diyl)bis(2-hydroxybenzoic acid)
- Benzoic acid, 3,3'-azobis(6-hydroxy-
- Olsalazine (INN)
- (E)-5,5'-(diazene-1,2-diyl)bis(2-hydroxybenzoic acid)
- mordant yellow 5
- OLSALAZINE [INN]
- 3,3'-diazene-1,2-diylbis(6-hydroxybenzoic acid)
- Olsalazinum [Latin]
- Olsalazina [Spanish]
- Dipentium
- Rasal
- Olsalazine [INN:BAN]
- MFCD00602469
- C.I. Mordant Yellow 5
- Salicylic acid, 5,5'-azodi-
- UNII-ULS5I8J03O
- starbld0009635
- OLSALAZINE [MI]
- OLSALAZINE [VANDF]
- C07323
- CJ91B
- OLSALAZINE [WHO-DD]
- SCHEMBL25118
- SCHEMBL25119
- SCHEMBL29768
Look up olsalazine in the interactive SynDRA portal →